{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:41:32Z","timestamp":1792575692713,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute exacerbations of chronic obstructive pulmonary disease (COPD) are major clinical events associated with hospitalization, intensive care unit (ICU) admission, and increased mortality. Blood eosinophil count has emerged as a potential inflammatory biomarker in COPD; however, its role in predicting ICU requirement among hospitalized patients remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included patients aged\u2009\u2265\u200940 years hospitalized with acute COPD exacerbation at Ankara Bilkent City Hospital between 2020 and 2024. COPD diagnosis was based on Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. Blood eosinophil counts measured within the first 60\u00a0min of presentation to the emergency department were categorized as &lt;\u2009150 cells\/\u00b5L, 150\u2013299 cells\/\u00b5L, and \u2265\u2009300 cells\/\u00b5L. ICU admission was defined as the primary outcome. Competing risk analysis using the Fine\u2013Gray model was performed, with death as a competing event.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 385 patients were included. Eosinophil groups were not significantly associated with ICU requirement. Clinical variables significantly associated with ICU admission included GOLD group, GOLD grade, modified Medical Research Council (mMRC) dyspnea score, long-term oxygen therapy (LTOT), nebulizer and non-invasive mechanical ventilation (NIMV) use, and need for NIMV at admission. In Fine\u2013Gray models, GOLD group E was independently associated with increased ICU admission risk compared with GOLD A (subdistribution hazard ratio [sHR]\u2009=\u20093.35, 95% confidence interval [CI]\u2009=\u20091.57\u20137.15;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), whereas eosinophil levels were not.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In hospitalized patients with acute COPD exacerbations, blood eosinophil count \u2014 regardless of the threshold applied \u2014 was not independently associated with ICU admission after adjustment for disease severity and competing risks. GOLD group E emerged as the strongest independent predictor of ICU requirement in the same model. These findings suggest that clinical severity assessment, rather than eosinophil-based stratification, should guide risk assessment for ICU admission in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-026-04725-x","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:43:30Z","timestamp":1789130610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blood eosinophil count and intensive care unit admission in patients hospitalized for acute exacerbation of COPD: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8394-6544","authenticated-orcid":false,"given":"Umran","family":"Ozden Sertcelik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4301-0586","authenticated-orcid":false,"given":"Ahmet","family":"Sertcelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"issue":"11","key":"4725_CR1","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/thx.2005.040527","volume":"60","author":"JJ Soler-Cataluna","year":"2005","unstructured":"Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925\u201331.","journal-title":"Thorax"},{"issue":"7","key":"4725_CR2","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1164\/rccm.202301-0106PP","volume":"207","author":"A Agusti","year":"2023","unstructured":"Agusti A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, Bourbeau J, Han MK, Martinez FJ, Montes de Oca M, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Am J Respir Crit Care Med. 2023;207(7):819\u201337.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"4725_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1183\/09031936.00062614","volume":"44","author":"M Bafadhel","year":"2014","unstructured":"Bafadhel M, Davies L, Calverley PM, Aaron SD, Brightling CE, Pavord ID. Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis. Eur Respir J. 2014;44(3):789\u201391.","journal-title":"Eur Respir J"},{"issue":"6","key":"4725_CR4","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","volume":"184","author":"M Bafadhel","year":"2011","unstructured":"Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, McCormick M, Haldar K, Kebadze T, Duvoix A, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662\u201371.","journal-title":"Am J Respir Crit Care Med"},{"key":"4725_CR5","doi-asserted-by":"crossref","unstructured":"Singh D, Kolsum U, Brightling CE, Locantore N, Agusti A, Tal-Singer R. investigators E: Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44(6):1697\u20131700.","DOI":"10.1183\/09031936.00162414"},{"issue":"9","key":"4725_CR6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1164\/rccm.201509-1869OC","volume":"193","author":"S Vedel-Krogh","year":"2016","unstructured":"Vedel-Krogh S, Nielsen SF, Lange P, Vestbo J, Nordestgaard BG. Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study. Am J Respir Crit Care Med. 2016;193(9):965\u201374.","journal-title":"Am J Respir Crit Care Med"},{"key":"4725_CR7","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: 2025 Report. Global Initiative for Chronic Obstructive Lung Disease; 2024. Available from: https:\/\/goldcopd.org\/2025-gold-report\/.\u00a0Accessed 5\u00a0Mar 2026."},{"issue":"1","key":"4725_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12931-019-1268-7","volume":"21","author":"TH Harries","year":"2020","unstructured":"Harries TH, Rowland V, Corrigan CJ, Marshall IJ, McDonnell L, Prasad V, Schofield P, Armstrong D, White P. Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis. Respir Res. 2020;21(1):3.","journal-title":"Respir Res"},{"issue":"1","key":"4725_CR9","first-page":"10","volume":"10","author":"MH Rahimi-Rad","year":"2015","unstructured":"Rahimi-Rad MH, Asgari B, Hosseinzadeh N, Eishi A. Eosinopenia as a Marker of Outcome in Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Maedica (Bucur). 2015;10(1):10\u20133.","journal-title":"Maedica (Bucur)"},{"key":"4725_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.hrtlng.2022.05.012","volume":"56","author":"W Ruiying","year":"2022","unstructured":"Ruiying W, Zhaoyun, Jianying X. Clinical features and three-year prognosis of AECOPD patients with different levels of blood eosinophils. Heart Lung. 2022;56:29\u201339.","journal-title":"Heart Lung"},{"key":"4725_CR11","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.2147\/COPD.S88058","volume":"10","author":"C Salturk","year":"2015","unstructured":"Salturk C, Karakurt Z, Adiguzel N, Kargin F, Sari R, Celik ME, Takir HB, Tuncay E, Sogukpinar O, Ciftaslan N, et al. Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit? Int J Chron Obstruct Pulmon Dis. 2015;10:1837\u201346.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4725_CR12","doi-asserted-by":"crossref","unstructured":"Citgez E, van der Palen J, van der Valk P, Kerstjens HAM, Brusse-Keizer M. Stability in eosinophil categorisation during subsequent severe exacerbations of COPD. BMJ Open Respir Res. 2021;8(1):e000960.","DOI":"10.1136\/bmjresp-2021-000960"},{"issue":"2","key":"4725_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.chest.2016.10.003","volume":"151","author":"S Couillard","year":"2017","unstructured":"Couillard S, Larivee P, Courteau J, Vanasse A. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions. Chest. 2017;151(2):366\u201373.","journal-title":"Chest"},{"key":"4725_CR14","unstructured":"Ankara Bilkent City Hospital: About us. https:\/\/ankarasehir.saglik.gov.tr\/EN-845880\/about-us.html (2026). https:\/\/ankarasehir.saglik.gov.tr\/EN-845880\/about-us.html.\u00a0Accessed 5 Mar 2026."},{"issue":"7","key":"4725_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/thx.54.7.581","volume":"54","author":"JC Bestall","year":"1999","unstructured":"Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581\u20136.","journal-title":"Thorax"},{"issue":"2","key":"4725_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1513\/AnnalsATS.201208-043OC","volume":"10","author":"A Singanayagam","year":"2013","unstructured":"Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2013;10(2):81\u20139.","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"4725_CR17","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/thorax-2022-219463","volume":"78","author":"C Echevarria","year":"2023","unstructured":"Echevarria C, Steer J, Prasad A, Quint JK, Bourke SC. Admission blood eosinophil count, inpatient death and death at 1 year in exacerbating patients with COPD. Thorax. 2023;78(11):1090\u20136.","journal-title":"Thorax"},{"key":"4725_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2147\/COPD.S289920","volume":"16","author":"J Yang","year":"2021","unstructured":"Yang J, Yang J. Association Between Blood Eosinophils and Mortality in Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study. Int J Chron Obstruct Pulmon Dis. 2021;16:281\u20138.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4725_CR19","doi-asserted-by":"publisher","first-page":"107501","DOI":"10.1016\/j.rmed.2023.107501","volume":"222","author":"H Liu","year":"2024","unstructured":"Liu H, Xie Y, Huang Y, Luo K, Gu Y, Zhang H, Xu Y, Chen X. The association between blood eosinophils and clinical outcome of acute exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis. Respir Med. 2024;222:107501.","journal-title":"Respir Med"},{"key":"4725_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2147\/COPD.S396311","volume":"18","author":"J Pu","year":"2023","unstructured":"Pu J, Yi Q, Luo Y, Wei H, Ge H, Liu H, Li X, Zhang J, Pan P, Zhou H, et al. Blood Eosinophils and Clinical Outcomes in Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study. Int J Chron Obstruct Pulmon Dis. 2023;18:169\u201379.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"446","key":"4725_CR21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JPGR Fine","year":"1999","unstructured":"Fine JPGR. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496\u2013509.","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"4725_CR22","doi-asserted-by":"publisher","first-page":"19097","DOI":"10.1038\/s41598-025-05033-w","volume":"15","author":"H Ogata","year":"2025","unstructured":"Ogata H, Tsubouchi K, Takano T, Ichiki K, Torii R, Takata S, Nakagaki N, Yoshida M, Kitasato Y, Tobino K, et al. Mortality and exacerbation risk according to GOLD and STAR severity stages of COPD: a 5-year multicenter prospective cohort study. Sci Rep. 2025;15(1):19097.","journal-title":"Sci Rep"},{"key":"4725_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/COPD.S27480","volume":"7","author":"C Tantucci","year":"2012","unstructured":"Tantucci C, Modina D. Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:95\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"4725_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s12890-025-03959-5","volume":"25","author":"R Gao","year":"2025","unstructured":"Gao R, Zheng S, Shen X, Xu L, Hong H. Nonlinear association between blood eosinophil counts and clinical outcomes in ICU-Admitted patients with acute exacerbation of COPD: a retrospective observational study. BMC Pulm Med. 2025;25(1):489.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"4725_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1164\/rccm.202201-0209PP","volume":"206","author":"D Singh","year":"2022","unstructured":"Singh D, Agusti A, Martinez FJ, Papi A, Pavord ID, Wedzicha JA, Vogelmeier CF, Halpin DMG. Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review. Am J Respir Crit Care Med. 2022;206(1):17\u201324.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"4725_CR26","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1164\/rccm.201701-0009LE","volume":"195","author":"OA Oshagbemi","year":"2017","unstructured":"Oshagbemi OA, Burden AM, Braeken DCW, Henskens Y, Wouters EFM, Driessen JHM, Maitland-van der Zee AH, de Vries F, Franssen FME. Stability of Blood Eosinophils in Patients with Chronic Obstructive Pulmonary Disease and in Control Subjects, and the Impact of Sex, Age, Smoking, and Baseline Counts. Am J Respir Crit Care Med. 2017;195(10):1402\u20134.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04725-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04725-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04725-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:55:32Z","timestamp":1792572932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04725-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4725"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04725-x","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"13 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board of Ankara Bilkent City Hospital (approval date: March 4, 2026, approval number: TABED 2-26-2024). Owing to the retrospective observational design of the study and the use of anonymized patient data extracted from electronic medical records, the requirement for individual informed consent was waived by the institutional review board. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"489"}}